PCLO.V - PharmaCielo Ltd.

TSXV - TSXV Delayed Price. Currency in CAD
6.95
-0.55 (-7.33%)
At close: 4:00PM EDT
Stock chart is not supported by your current browser
Previous Close7.50
Open7.38
Bid6.96 x 0
Ask6.98 x 0
Day's Range6.80 - 7.49
52 Week Range6.28 - 11.50
Volume360,786
Avg. Volume247,376
Market Cap668.071M
Beta (3Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.31
Earnings DateJul 15, 2019 - Jul 25, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est8.90
  • PharmaCielo Announces Results of AGM
    CNW Group2 days ago

    PharmaCielo Announces Results of AGM

    TORONTO and RIONEGRO, Colombia , May 24, 2019 /CNW/ -  PharmaCielo Ltd.  (" PharmaCielo " or the " Company ") ( TSXV:PCLO ), the Canadian parent of Colombia's premier cultivator and ...

  • Is Colombia Poised to Become the Saudi Arabia of Cannabis?
    The Motley Fool18 days ago

    Is Colombia Poised to Become the Saudi Arabia of Cannabis?

    Colombia's substantial comparative advantage for cannabis cultivation makes now the time to buy PharmaCielo Ltd. (TSXV:PCLO).

  • Ups and Downs in the Cannabis Space Last Week
    Market Realist27 days ago

    Ups and Downs in the Cannabis Space Last Week

    Cannabis Updates: Price Action, Ratings, and MoreCannabis spaceThe cannabis space was mostly positive last week. The Horizons Marijuana Life Sciences ETF (HMMJ) and the ETFMG Alternate Harvest ETF (MJ) gained 5.2% and 4.2%, respectively, while the

  • Profiting from Marijuana in Pablo Escobar’s Old Neighbourhood
    The Motley Foollast month

    Profiting from Marijuana in Pablo Escobar’s Old Neighbourhood

    The time has arrived for investors seeking exposure to cannabis to buy PharmaCielo (TSXV:PCLO).

  • Cannabis Updates: New Listings, Price Action, and Ratings
    Market Realistlast month

    Cannabis Updates: New Listings, Price Action, and Ratings

    Cannabis Updates: New Listings, Price Action, and RatingsCannabis updateThe cannabis sector showed some weakness last week, and the Horizons Marijuana Life Sciences ETF (HMMJ) lost 3.0% while the ETFMG Alternate Harvest ETF (MJ) lost 3.4%.

  • CNW Grouplast month

    Latin American Countries Offer Unique Benefits to Cannabis Cultivators

    Predominantly, most countries which have adopted cannabis legislation have legalized the plant specifically for medical purposes. Countries such as Argentina, Chile, Colombia, and Brazil have all legalized medical cannabis, while some have also decriminalized cannabis, allowing for moderate personal consumption. In combination, all of these factors are further accelerating the Latin American cannabis industry by inviting new business opportunities.

  • PharmaCielo Announces its Financial Results for the Fourth Quarter and Fiscal Year 2018
    CNW Grouplast month

    PharmaCielo Announces its Financial Results for the Fourth Quarter and Fiscal Year 2018

    Oil processing facility is on track for commercial operation and GMP certification during Q3-2019, enabling large-scale production and sale of refined cannabis oil. Currently, 10 hectares are under active cultivation, expanding to 20 hectares (~2.15 million square feet) by year-end 2019, backed by 20 proprietary registered strains and 186 strains in the Company's germplasm bank. PharmaCielo's common shares began trading on the TSX Venture Exchange ("TSXV" or "TSX Venture") under the ticker PCLO on January 18, 2019.

  • CNW Grouplast month

    Tourists Find New and Destination-Worthy Attractions in Cannabis

    Additionally, a survey conducted by Colorado Tourism reported that 12 million, or approximately 15%, of those travelers participated in marijuana-related activities. Around the world, even though the cannabis industry remains in its infancy stage, more and more countries continue to legalize the plant. Thusly, the consumer base is projected to grow, propelling the overall market even further, as according to data compiled by Mordor Intelligence, the global cannabis market was valued at USD 7.7 Billion in 2016 and is expected to reach USD 65 Billion by 2023.

  • The Irony of Colombia’s Nascent Pot Boom
    The Motley Foollast month

    The Irony of Colombia’s Nascent Pot Boom

    PharmaCielo Ltd. (TSXV:PCLO) could be the next big marijuana stock.

  • Could The PharmaCielo Ltd. (CVE:PCLO) Ownership Structure Tell Us Something Useful?
    Simply Wall St.last month

    Could The PharmaCielo Ltd. (CVE:PCLO) Ownership Structure Tell Us Something Useful?

    Every investor in PharmaCielo Ltd. (CVE:PCLO) should be aware of the most powerful shareholder groups. Generally speaking, as a company grows, institutions will increase their ownership. Conversely, insiders often decrease their ow...

  • ACCESSWIRElast month

    The Top 3 Cannabis Companies with a Focus on International Expansion

    In their report, "The Road Map to $57 Billion Worldwide Market," analysts note that the South American market for example could grow from $125 million in 2018 to $776 million by 2027. The Yield Growth Corporation (BOSS)(BOSQF) just entered into an agreement with Pontier Services to set up Urban Juve hemp beauty products for e-commerce sales in WeChat, in addition to launching a marketing campaign with AI-enabled pop-up kiosks to rotate through six major locations in Hong Kong beginning in June 2019. Such a move will establish Urban Juve as the first Canadian brand to launch Pop Square AI-enabled pop-up kiosks in China.

  • CNW Group2 months ago

    PharmaCielo Appoints New and Extended Medical and Scientific Advisory Board

    TORONTO and RIONEGRO, Colombia, April 9, 2019 /CNW/ - David Attard, Chief Executive Officer of PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce the appointment of the Company's extended Medical and Scientific Advisory Board (MSAB).

  • ACCESSWIRE2 months ago

    Cannabis Companies are Just Beginning to Expand Global Footprint

    HOUSTON, TX / ACCESSWIRE / April 4, 2019 / Over the next decade, spending on worldwide cannabis could reach $57 billion by 2027, according to Arcview Market Research and BDS Analytics. In their report, ...

  • CNW Group2 months ago

    PharmaCielo Doubles Its Portfolio of Proprietary Cannabis Strains Approved for Colombia's Cultivar Registration

    TORONTO and RIONEGRO, COLOMBIA, March 29, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received from the national cultivar registry approval for the listing of a further 10 strains, each of which has a prominent tetrahydrocannabinol (THC) profile. The additional registration of the new strains to the national cultivar registry, including a unique 1:1 THC to CBD ratio strain, doubles the number of approved strains PharmaCielo holds in the registry, making it the largest holder of approved strains in Colombia.

  • Market Exclusive2 months ago

    PharmaCielo Becomes 1st Colombia’s Cannabis Producer to Earn ISO Certification

    PharmaCielo Ltd. (OTCMKTS:PHCEF), which owns Colombia's based medicinal-grade cannabis oil cultivator and producer PharmaCielo Colombia Holdings S.A.S., said that they have received the ISO 9001:2015 certification for its cultivation and extraction operations. ISO 9001 is the international standard that specifies requirements for a quality management system. Organizations use the standard to show their ability to […]The post PharmaCielo Becomes 1st Colombia's Cannabis Producer to Earn ISO Certification appeared first on Market Exclusive.

  • Market Exclusive2 months ago

    Cannabis Stock News Daily Roundup March 19

    Canopy Growth (TSX: WEED) (NYSE: CGC) and OG DNA Genetics have signed an new partnership agreement. Under the terms of the agreement, the companies will work together to expand into global markets, including Europe. GB Sciences (OTCQB: GBLX) launched a Canada-based cannabinoid medicine company GBS Global Biopharma. The company will develop cannabinoid medicines for medical […]The post Cannabis Stock News Daily Roundup March 19 appeared first on Market Exclusive.

  • PharmaCielo Receives ISO 9001 Quality Assurance Certification for its Medicinal Cannabis Cultivation and Processing Operations in Colombia
    CNW Group2 months ago

    PharmaCielo Receives ISO 9001 Quality Assurance Certification for its Medicinal Cannabis Cultivation and Processing Operations in Colombia

    TORONTO and RIONEGRO, Colombia, March 19, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., is pleased to announce the Company has received the ISO 9001:2015 certification for its cultivation and extraction operations.

  • CNW Group3 months ago

    Cannabis Companies Continue Their Growth With New Institutional Backing

    NEW YORK, March 5, 2019 /CNW/ -- The cannabis industry has recently been finding backers in major global investment banking firms such as Piper Jaffray, RBC Capital Markets, and Cowen. Piper Jaffray analyst Michael Lavery noted that there are more than 25 countries that have legalized marijuana of some form. According to data compiled by MarketsandMarkets, the global cannabis market is projected to grow from USD 10.3 Billion in 2018 to USD 39.4 Billion by 2023.

  • Baystreet3 months ago

    The Top Cannabis Stocks with a Powerful Colombian Market Catalyst

    With favorable cannabis-growing conditions, Colombia is quickly emerging as an industry hot spot. In ...

  • CNW Group3 months ago

    Cannabis Companies Pursuing Growth Set Sights on Latina America

    NEW YORK, Feb. 28, 2019 /CNW/ --The Latin America region has become highly sought after for cannabis businesses due to the opportunities it represents. Around the globe, many cannabis businesses have moved to establish operations in LATAM because of the area's low cultivation costs and fertile farming lands, as countries including Peru, Chile, Argentina, and Colombia have all passed favourable medical cannabis laws. Meanwhile, Uruguay has entirely legalized cannabis for both recreational and medical use.

  • CNW Group3 months ago

    Countries Following in Canada's Footsteps on Cannabis Legalization

    NEW YORK, Feb. 25, 2019 /CNW/ -- Following Canada's legalization of cannabis, the North American cannabis industry is positioned to account for the majority of the global marketplace. Canada legalized recreational cannabis nationwide in October, making it the first G-7 country to do so. Now, Mexico's President-elect party is moving to legalize cannabis as well.

  • CNW Group3 months ago

    Continued Market Expansion is Driving Cannabis Companies to New Regions

    NEW YORK, Feb. 19, 2019 /CNW/ -- The expansion of the cannabis industry has led companies involved in the marketplace to expand internationally as larger players are extending their operations into other regions such as Europe and Latin America. According to Verified Market Intelligence, the global marijuana market was valued at USD 42.20 Billion in 2017 and is expected to reach USD 466.81 Billion by 2025. The market is primarily being accelerated by the growing adoption of medical cannabis for the treatment of chronic diseases.

  • CNW Group3 months ago

    Cannabis Businesses Eye Latin America in Effort to Reduce Costs

    NEW YORK, Feb. 14, 2019 The cannabis industry is an attractive investment opportunity for entrepreneurs, however, entering into the market poses a challenge for many. In order to mitigate their losses, many began to establish operations in Latin America, specifically in countries such as Argentina, Brazil, Chile, Colombia, and Peru. According to data compiled by BDS Analytics in partnership with Arcview Research, the South American legal cannabis spending is expected to grow from USD 125 Million in 2018 to USD 776 Million by 2026.

  • ACCESSWIRE3 months ago

    Top 3 Cannabis Stocks Higher on Colombian Growth Story

    HOUSTON, TX / ACCESSWIRE / February 14, 2019 / Colombia is just beginning to transform itself into a multi-billion-dollar cannabis producer for the pharmaceutical industry. "Colombia is wooing foreign investors, talking up its potential in the new era of peace as a resource-rich country with a business-friendly regulatory environment," noted The Globe and Mail. Blueberries Medical Corp. (BBM), for example, just entered into a letter of intent for a joint venture with Harmony and Life S.A.S., operating as El Manantial medical centers.

  • CNW Group4 months ago

    PharmaCielo Receives Approval for Cultivar Registration of 10 Proprietary Cannabis Strains

    TORONTO and RIONEGRO, Colombia, Feb. 6, 2019 /CNW/ - PharmaCielo Ltd. ("PharmaCielo" or the "Company") (TSXV:PCLO), the Canadian parent of Colombia's premier cultivator and producer of medicinal-grade cannabis oil, PharmaCielo Colombia Holdings S.A.S., announced today that its Colombian subsidiary has received approval for the listing of 10 proprietary and unique tetrahydrocannabinol (THC) and cannabidiol (CBD) strains with the national cultivar registry. The Company can now proceed to commercial registration, production and sale of these strains within Colombia as well as for export to global markets.